Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.


GREY:IVITF - Post by User

Comment by display_nameon Dec 30, 2018 4:23pm
244 Views
Post# 29169974

RE:Trying to get a good read on this company

RE:Trying to get a good read on this company
The big detractors right off the bat are the 15 million in capital they misused bringing on gene Simmons and there is the argument that they may have spent too much on the gtec aquisition. However all the money they've raised in the last two rounds of financing have been between 1.60 and 2/share so there are institutional players happy to hang on to shares and warrants at those prices, taking that as a buy signal personally. Overall they have a pretty ambitious capacity expansion plan which they've been pretty near meeting so far. I believe they will be able to move their product at a higher aggregate profit margin with their recent clinic/retail expansion plan as well.
<< Previous
Bullboard Posts
Next >>